Related Experiment Videos
Neuroendocrine adaptations in renal disease
Reinhard Feneberg1, Franz Schaefer, Johannes D Veldhuis
1Coordination Centre for Clinical Trials, Im Neuenheimer Feld 221, 69120, Heidelberg, Germany.
Pediatric Nephrology (Berlin, Germany)
|May 3, 2003
Summary
Chronic renal failure (CRF) disrupts hormone secretion patterns, affecting growth hormone (GH) and luteinizing hormone (LH) release. This review details how CRF impairs pulsatile hormone release, leading to hormonal imbalances and potential therapeutic challenges.
Area of Science:
- Endocrinology
- Nephrology
- Physiology
Background:
- Chronic renal failure (CRF) significantly disrupts the body's hormonal balance.
- Pulsatile secretion of peptide hormones is critical for physiological regulation.
- CRF affects both the synthesis and release of key hormones at the hypothalamo-pituitary level.
Purpose of the Study:
- To review the impact of CRF on the pulsatile release of peptide hormones.
- To examine the mechanisms underlying altered hormone secretion in CRF.
- To discuss the consequences of distorted secretory dynamics in CRF.
Main Methods:
- Review of experimental evidence on hypothalamo-pituitary function in CRF.
- Analysis of studies assessing parathyroid hormone (PTH) and insulin secretion patterns.
- Examination of factors influencing hormone release, including autonomic innervation and metabolic drives.
Main Results:
- CRF leads to impaired tissue actions, disorderly release patterns, and deficiencies in growth hormone (GH) and luteinizing hormone (LH).
- CRF reduces hypothalamic releasing factors (GHRH, LHRH) and increases somatostatin inhibition.
- Abnormalities in PTH and insulin secretion, including diminished mass per burst and altered pulse frequency, are common in CRF.
Conclusions:
- CRF causes significant disruptions in the pulsatile secretion of critical peptide hormones.
- Impaired hormonal dynamics, tissue resistance, and altered clearance contribute to the pathophysiology of CRF.
- Understanding these secretory disturbances is vital for managing CRF and its related complications, including guiding therapeutic interventions like GH supplementation.